Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Ozpolat

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Molecular Cancer Therapeutics|April 7, 2023
Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast CancerRumeysa Ozyurt, Bulent Ozpolat
Non-Coding RNA|March 6, 2021
The Role of LncRNAs in TranslationDidem Karakas, Bulent Ozpolat
Advances in Experimental Medicine and Biology|November 12, 2025
The Role of Proinflammatory Biomarkers in Oral Cancer PathophysiologyBusra Yilmaz, Bulent Ozpolat
Biomedical Microdevices|February 7, 2024
SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancerGoknur Kara, Bulent Ozpolat
Cancers|July 29, 2023
Mechanisms of PARP-Inhibitor-Resistance in BRCA-Mutated Breast Cancer and New Therapeutic ApproachesSayra Dilmac, Bulent Ozpolat
Anticancer Research|February 4, 2019
MicroRNA-based Targeted Therapeutics in Pancreatic CancerNilgun Gurbuz, Bulent Ozpolat
Journal of Molecular Medicine (Berlin, Germany)|May 8, 2020
Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular targetDidem Karakas, Bulent Ozpolat
Cancers|November 11, 2022
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted TherapiesRumeysa Ozyurt, Bulent Ozpolat
Cancers|February 10, 2024
PIM3 Kinase: A Promising Novel Target in Solid CancersPinar Atalay, Bulent Ozpolat
Cancer Management and Research|September 23, 2015
Targeting autophagy in cancer management - strategies and developmentsBulent Ozpolat, Doris M Benbrook
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|April 7, 2023
Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast CancerRumeysa Ozyurt, Bulent Ozpolat
Non-Coding RNA|March 6, 2021
The Role of LncRNAs in TranslationDidem Karakas, Bulent Ozpolat
Advances in Experimental Medicine and Biology|November 12, 2025
The Role of Proinflammatory Biomarkers in Oral Cancer PathophysiologyBusra Yilmaz, Bulent Ozpolat
Biomedical Microdevices|February 7, 2024
SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancerGoknur Kara, Bulent Ozpolat
Cancers|July 29, 2023
Mechanisms of PARP-Inhibitor-Resistance in BRCA-Mutated Breast Cancer and New Therapeutic ApproachesSayra Dilmac, Bulent Ozpolat
Anticancer Research|February 4, 2019
MicroRNA-based Targeted Therapeutics in Pancreatic CancerNilgun Gurbuz, Bulent Ozpolat
Journal of Molecular Medicine (Berlin, Germany)|May 8, 2020
Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular targetDidem Karakas, Bulent Ozpolat
Cancers|November 11, 2022
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted TherapiesRumeysa Ozyurt, Bulent Ozpolat
Cancers|February 10, 2024
PIM3 Kinase: A Promising Novel Target in Solid CancersPinar Atalay, Bulent Ozpolat
Cancer Management and Research|September 23, 2015
Targeting autophagy in cancer management - strategies and developmentsBulent Ozpolat, Doris M Benbrook
Pageof 14